🇺🇸#акции #сша #premarket
премаркет США - акции - заметные движения:
ВВЕРХ
#VRNA +59% Verona Pharma plc - reported primary endpoint met at all doses in 4 week Phase 2b COPD study with nebulized ensifentrine on top of tiotropium therapy.
#CPAH +25% CounterPath Corporation - after climbing 304% on Friday.
#ENLV +20% Enlivex Therapeutics Ltd.
#NVTA +13% Invitae Corporation - said it generated revenue of $216 million in 2019, up more than 45% versus the $147.7 million in 2018.
#SFET +10% Safe-T Group Ltd - expects FY 2019 revenue of $3.27 million-$3.37 million, and Q4 revenue of $1.1 million-$1.2 million.
#HOME +10% At Home Group Inc. - raised its Q4 guidance.
#AMRN +10% Amarin Corporation plc -reported the launche of True To Your Heart, a campaign to educate people on persistent cardiovascular risk.
#OBSV +9% ObsEva SA - announced sublicense agreement to develop and commercialize Nolasiban in the People's Republic of China.
#JMEI +8% Jumei International Holding Limited - after falling 6% on Friday.
#BLDP +7% Ballard Power Systems Inc. - after gaining 6% on Friday.
#EDSA +7% Edesa Biotech, Inc. - after surging 13% on Friday.
#CYCN +7% Cyclerion Therapeutics, Inc. - company is likely to release Phase 1 data for IW-6463 from the study of healthy volunteers at the JPMorgan Healthcare Conference.
#AXSM +6% Axsome Therapeutics, Inc. - entered into an exclusive license agreement with Pfizer for Pfizer's reboxetine clinical and nonclinical data and for new Phase 3 esreboxetine product candidate.
#AXGT +6% Axovant Gene Therapies Ltd. - reported 'positive' 12-month data on AXO-Lenti-PD and issued updates across gene therapy pipeline programs.
#NIO +6% NIO Limited
#LGND +5% Ligand Pharmaceuticals Incorporated
#BYND +4% Beyond Meat, Inc. - Chinese plant-based meat substitute founder Vince Lu said entrance of Beyond Meat, Impossible Foods to China can raise the exposure of plant-based foods in the country.
#FINV +4% FinVolution Group
#OCX +3% OncoCyte Corp - announced plans to acquire Insight Genetics for $12 million.
ВНИЗ
#SSI -32% Stage Stores, Inc. - reported a 1.4% year-over-year rise in its holiday same-store sales. The company said it expects 2019 earnings to be $25 million-$30 million below the low end of its previously given guidance range.
#APOP -9% Cellect Biotechnology Ltd. - after rising 5% on Friday.
#HEAR -8% Turtle Beach Corporation
#CYCC -4% Cyclacel Pharmaceuticals Inc - announced it received a notice of delisting or failure to satisfy a continued listing rule or standard.
#SLB -4% Schlumberger Limited
#EXEL -3% Exelixis, Inc. - projects FY 2019 revenue of $972 million and Q4 revenue of $245 million.
